What Does the Current and Future Market Size Analysis Say about the Cancer Immunotherapy Industry?
The cancer immunotherapy market size has experienced remarkable growth recently, expanding from $110.91 billion in 2024 to $125.68 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. Factors contributing to this growth include the rising prevalence of cancer, increased adoption of immunotherapy over traditional therapies, booming research and development activities for targeted diseases, and the effectiveness and accuracy of newer therapies.
This robust growth is forecast to continue, with the cancer immunotherapy market predicted to reach $194.64 billion in 2029, at a CAGR of 11.6%. The growth during this period is expected to be driven by factors such as the increasing approval of novel immunotherapies for cancer treatment, surging demand for personalized medicine, increased investment in clinical trials for new treatments, and growing awareness about cancer immunotherapy.
Grab Your Free Sample of The Global Cancer Immunotherapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6768&type=smp
What are the Key Drivers Boosting the Demand for Cancer Immunotherapy?
The escalating incidence of cancer globally is among the primary factors propelling the cancer immunotherapy market. The surge in cancer cases worldwide, attributed to factors including tobacco and alcohol usage, obesity, sedentary lifestyles, and environmental influences, is boosting demand for cancer immunotherapies. For example, the European Union Science Hub stated that new cancer cases rose by 2.3% between 2021 and 2023, reaching 2.74 million in 2022. The increase in cancer incidence is set to continue fueling demand for cancer immunotherapy during the forecast period.
What are the Main Segments in the Cancer Immunotherapy Market?
The cancer immunotherapy market report encapsulates the following segments:
1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy
2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma
3) By End User: Hospitals, Cancer Research Centers, Clinics
For detailed insights, order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report
Who are the Major Players in the Cancer Immunotherapy Market?
Prominent companies operating in the cancer immunotherapy market include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, 3D Signatures Inc., Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, Kura Oncology Inc., MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG, Pfizer Inc., Pulse Biosciences Inc., Regeneron Pharmaceuticals Inc., Roche Holding AG, Targovax ASA, Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd., Turnstone Biologics Corp., Xencor Inc.
What are the Latest Trends in the Cancer Immunotherapy Market?
The utilization of advanced technologies in cancer immunotherapy is trending in the market. There’s a surge in new technologies and therapies that help the immune system identify and attack tumors, including immuno-oncology, cryoablation, bone marrow transplant, and radiation therapy. These technologies have the potential to revolutionize cancer treatment.
Which Region Leads in the Cancer Immunotherapy Market?
North America was the most extensive region in the cancer immunotherapy market in 2024 and is projected to be the fastest-growing region during the forecast period.
What Does The Cancer Immunotherapy Market Report 2025 Offer?
Cancer immunotherapy refers to a type of cancer therapy that enhances the body’s defenses against the disease. The body’s immune system helps resist infections and various disorders. Cancer immunotherapy comes in different forms, such as cytokines and vaccines, adoptive cell therapies, oncolytic viruses, tumor-infecting viruses, and others. The Cancer Immunotherapy Market research report from The Business Research Company offers insights into global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Unlock valuable market insights by purchasing the exclusive report now:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6768
Contact Information:
About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
